Literature DB >> 19182526

T cell dependence on mTOR signaling.

Robyn E Mills1, Julie M Jameson.   

Abstract

The mammalian target of rapamycin (mTOR) signaling pathway integrates signals from the environment to the nucleus for the regulation of cellular growth, metabolism and survival. Lymphocytes frequently rely on this pathway, but it is carefully regulated through the reception of signals via cytokine, growth factor and co-stimulatory receptors. Recent studies have begun to elucidate why T cell subsets rely on this pathway to varying degrees. Ultimately these findings will help distinguish the parameters that guide T cell homeostasis and activation-induced function between the different T cell populations. The mTOR pathway has been the focus of many immunosuppressive and cancer treatment regimens, therefore there is a great need to understand the impact of suppression not only on the T cell populations targeted, but on bystander T cells as well.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182526     DOI: 10.4161/cc.8.4.7625

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice.

Authors:  Ying Wang; Geoffrey Camirand; Yan Lin; Monica Froicu; Songyan Deng; Warren D Shlomchik; Fadi G Lakkis; David M Rothstein
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

Review 3.  The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

Authors:  Jonathan D Powell; Greg M Delgoffe
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

4.  Red blood cells carry out T cell growth and survival bioactivities that are sensitive to cyclosporine A.

Authors:  Ricardo F Antunes; Cláudia Brandão; Gonçalo Carvalho; Cristina Girão; Fernando A Arosa
Journal:  Cell Mol Life Sci       Date:  2009-10       Impact factor: 9.261

Review 5.  Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation.

Authors:  Alberto Baroja-Mazo; Beatriz Revilla-Nuin; Pablo Ramírez; José A Pons
Journal:  World J Transplant       Date:  2016-03-24

Review 6.  Regulation of immune responses by mTOR.

Authors:  Jonathan D Powell; Kristen N Pollizzi; Emily B Heikamp; Maureen R Horton
Journal:  Annu Rev Immunol       Date:  2011-11-29       Impact factor: 28.527

7.  Negative regulation of mTOR activation by diacylglycerol kinases.

Authors:  Balachandra K Gorentla; Chi-Keung Wan; Xiao-Ping Zhong
Journal:  Blood       Date:  2011-02-10       Impact factor: 22.113

8.  T cell proliferation and adaptive immune responses are critically regulated by protein phosphatase 4.

Authors:  Fang-Hsuean Liao; Wan-Yi Hsiao; Yu-Chun Lin; Yi-Chiao Chan; Ching-Yu Huang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturation.

Authors:  Hyewon Phee; Byron B Au-Yeung; Olga Pryshchep; Kyle Leonard O'Hagan; Stephanie Grace Fairbairn; Maria Radu; Rachelle Kosoff; Marianne Mollenauer; Debra Cheng; Jonathan Chernoff; Arthur Weiss
Journal:  Elife       Date:  2014-05-13       Impact factor: 8.140

10.  Protective role of p70S6K in intestinal ischemia/reperfusion injury in mice.

Authors:  Kechen Ban; Rosemary A Kozar
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.